Cite
HARVARD Citation
Schuurbiers, M. et al. (2022). Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC. Journal for immunotherapy of cancer. 10 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schuurbiers, M. et al. (2022). Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC. Journal for immunotherapy of cancer. 10 (2), p. . [Online].